Press Releases and Blog
Blog
Get The Facts: WSJ’s PBM Article Relied On Deeply Flawed Research—In Reality, PBMs Save Patients Billions
The Wall Street Journal recently published an article that, unfortunately, elevated a “study” conducted by an organization, 3 Axis Advisors (46brooklyn), with a long history
ICYMI: Labor Unions And Employers Rely On Pharmacy Benefits For Lower Health Care Costs
In case you missed it, recent media reports have attempted to paint a false picture about pharmacy benefit managers (PBMs). These reports fail to mention
ICYMI: RealClearHealth: JC Scott: Elevating The Value Of The Employer-PBM Relationship
In case you missed it, JC Scott, president and CEO of the Pharmaceutical Care Management Association (PCMA), highlights the valuable relationship between pharmacy benefit managers
What They Are Saying: Employers Across The Nation Urge Congress To Protect Their Pharmacy Benefits
America’s employers are increasingly highlighting the value that pharmacy benefit managers (PBMs) provide as critical partners in providing affordable, high-quality health care benefits for their
ICYMI: PCMA Launches New Campaign To Elevate The Voice Of The Employer-PBM Relationship
In case you missed it, the Pharmaceutical Care Management Association (PCMA) launched the How PBMs Work campaign to emphasize the importance of the relationship between
ICYMI: Medicare “Delinking” Does Not Result In Savings, Increases Costs For Seniors And Taxpayers
As a so-called “delinking” measure continues to be discussed in Congress, specifically in the Medicare Part D program, it’s important lawmakers understand that this policy
Press Releases
Waltz Health Joins Pharmaceutical Care Management Association
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) today announced that Waltz Health is joining the trade association as its newest member. “PCMA is
PCMA Supports Bill to Address Big Pharma’s Patent Thickets
New Bipartisan Legislation would Crack Down on Routine Abuse of the Drug Patent System to Keep More Affordable Alternatives Off Market (Washington, D.C.) — The
PCMA Report Details Increased Costs Associated with Legal Changes in Tennessee
Ever-Broadening Actions Will Increase Prescription Drug Spending by Nearly $5 Billion (Nashville, TN) — The Pharmaceutical Care Management Association (PCMA) today released a report finding that recent
PCMA Report Details What PBMs Are Doing to Improve Health Equity
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) today released a new, first-of-its-kind, progress report on the work PCMA member pharmacy benefit companies are
PCMA Statement on CMS Letter to Pharmacy Benefit Companies
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) issued the following statement in response to a letter issued by the Centers for Medicare and Medicaid Services
PCMA Statement On House Vote Of H.R. 5378
The Pharmaceutical Care Management Association (PCMA) released the following statement on the U.S. House of Representatives’ vote on the Lower Costs, More Transparency Act. “America’s
ICYMI: RealClearHealth: JC Scott: Let’s Get Drug Pricing Legislation Right
In case you missed it, JC Scott, president and CEO of the Pharmaceutical Care Management Association (PCMA), highlights the opportunity Congress now has to get
Patient Access and Insulin: Market Forces, Innovative PBM Programs Lowering Costs for Patients
The insulin market today is not the market of five years ago. The insulin market of the 2010s was defined by just three drug companies
Alex Brill: Trends In The US Insulin Market: New Prices, New Players, New Dynamics
“In effect, the era of high list prices and high rebates for insulin is over” In case you missed it, Alex Brill, founder and CEO
Economists Ike Brannon and Anthony Lo Sasso: The Real Challenge Facing Independent Pharmacies
As independent pharmacies conduct a “Fly-In” in Washington D.C this week, they will undoubtedly double-down on support for policies targeting pharmacy benefit companies that would
What They Are Saying: PBMs Help Businesses, Families, And Patients Save On Rx Costs, Allow Employers To Offer Competitive Benefits
Voices from around the nation, including small business owners and concerned citizens, have sounded the alarm on proposals targeting pharmacy benefit companies in Congress, specifically
Pharmacy Benefit Companies Partner To Support Rural Pharmacies And Patients
This week, community pharmacists will conduct a “Fly-In” in Washington D.C. Undoubtedly, part of the message to Congress will be critical of pharmacy benefit companies,
RealClearMarkets Op-Ed: “Attacks On Pharmacy Benefit Managers Won’t Reduce Drug Prices”
As Congress returns to Washington, Ike Brannon, senior fellow at the Jack Kemp Foundation, explains how state and federal efforts to undermine the role of
PBMs Support Competition and Innovation to Lower Prescription Drug Costs
The pharmacy benefit company market is competitive and diverse, with more than 70 full-service PBMs of varying size operating across the country. These companies differentiate themselves through the
Matrix Global Advisors Touts Biosimilar Interchangeability Proposal in Biden Administration Budget – SSR Health: Biosimilar Competition Leads to Significant Decline in Net Prices on Brand Humira
Pharmacy benefit companies are strong proponents of a highly functioning biosimilar market and have advocated for policy changes that will increase generic and biosimilar uptake
ICYMI: RealClearHealth: Pat Toomey: Attacking PBMs Won’t Solve President Biden’s Inflation Problem
In case you missed it, former U.S. Senator Pat Toomey (R-PA) explains how the Biden Administration’s recent push targeting pharmacy benefit companies is a deflecting